{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:43:11Z","timestamp":1778931791350,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1565-6","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T15:33:37Z","timestamp":1437665617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol"],"prefix":"10.1186","volume":"15","author":[{"given":"Jemima T.","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Noble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Chester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Lester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Parry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J.","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"issue":"9","key":"1565_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","volume":"2","author":"DM Parkin","year":"2001","unstructured":"Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2(9):533\u201343.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1565_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893\u2013917.","journal-title":"Int J Cancer"},{"issue":"9760","key":"1565_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","volume":"377","author":"MP Coleman","year":"2011","unstructured":"Coleman MP et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377(9760):127\u201338.","journal-title":"Lancet"},{"key":"1565_CR4","volume-title":"Cancer survival in England: Patients diagnosed 2005\u20132009 and followed up to 2010","author":"Office for National Statistics","year":"2011","unstructured":"Office for National Statistics. Cancer survival in England: Patients diagnosed 2005\u20132009 and followed up to 2010. London: ONS; 2011."},{"issue":"2","key":"1565_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.lungcan.2012.03.019","volume":"77","author":"M Behera","year":"2012","unstructured":"Behera M et al. Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis. Lung Cancer. 2012;77(2):331\u20138.","journal-title":"Lung Cancer"},{"issue":"9","key":"1565_CR6","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9","volume":"86","author":"WA Fry","year":"1999","unstructured":"Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer. 1999;86(9):1867\u201376.","journal-title":"Cancer"},{"key":"1565_CR7","unstructured":"Non-Small Cell Lung Cancer Collaborative Group, Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer. Cochrane Database Syst Rev. 2010(5): p. CD007309."},{"issue":"22","key":"1565_CR8","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1002\/cncr.26149","volume":"117","author":"MM Boxer","year":"2011","unstructured":"Boxer MM et al. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer. 2011;117(22):5112\u201320.","journal-title":"Cancer"},{"issue":"8","key":"1565_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/JTO.0b013e31818020c3","volume":"3","author":"SK Vinod","year":"2008","unstructured":"Vinod SK et al. Gaps in optimal care for lung cancer. J Thorac Oncol. 2008;3(8):871\u20139.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"1565_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.5694\/mja13.10331","volume":"199","author":"PL Mitchell","year":"2013","unstructured":"Mitchell PL et al. Lung cancer in Victoria: are we making progress? Med J Aust. 2013;199(10):674\u20139.","journal-title":"Med J Aust"},{"issue":"Suppl 2","key":"1565_CR11","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0169-5002(02)00357-4","volume":"38","author":"C Gridelli","year":"2002","unstructured":"Gridelli C. Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer? Lung Cancer. 2002;38 Suppl 2:S45\u201350.","journal-title":"Lung Cancer"},{"issue":"10","key":"1565_CR12","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1002\/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8","volume":"92","author":"CJ Sweeney","year":"2001","unstructured":"Sweeney CJ et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer. 2001;92(10):2639\u201347.","journal-title":"Cancer"},{"issue":"6","key":"1565_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"1565_CR14","volume-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"DA Karnofsky","year":"1949","unstructured":"Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. New York: Columbia University Press; 1949."},{"issue":"7","key":"1565_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0959-8049(95)00664-8","volume":"32A","author":"G Buccheri","year":"1996","unstructured":"Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996;32A(7):1135\u201341.","journal-title":"Eur J Cancer"},{"issue":"11","key":"1565_CR16","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1200\/JCO.1986.4.11.1604","volume":"4","author":"JP O\u2019Connell","year":"1986","unstructured":"O\u2019Connell JP et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol. 1986;4(11):1604\u201314.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1565_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/bjc.1993.140","volume":"67","author":"JB Sorensen","year":"1993","unstructured":"Sorensen JB et al. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 1993;67(4):773\u20135.","journal-title":"Br J Cancer"},{"issue":"10","key":"1565_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/JTO.0b013e318186a272","volume":"3","author":"E Dajczman","year":"2008","unstructured":"Dajczman E et al. Should patient-rated performance status affect treatment decisions in advanced lung cancer? J Thorac Oncol. 2008;3(10):1133\u20136.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1565_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/jpm.2006.9.309","volume":"9","author":"M Montoya","year":"2006","unstructured":"Montoya M et al. Objective evaluation of physical function in patients with advanced lung cancer: a preliminary report. J Palliat Med. 2006;9(2):309\u201316.","journal-title":"J Palliat Med"},{"issue":"7","key":"1565_CR20","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/JTO.0b013e3181da85e4","volume":"5","author":"SK Vinod","year":"2010","unstructured":"Vinod SK et al. Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol. 2010;5(7):1025\u201332.","journal-title":"J Thorac Oncol"},{"key":"1565_CR21","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/S0169-5002(13)70103-X","volume":"79","author":"L Pemberton","year":"2013","unstructured":"Pemberton L et al. Do treatment decisions made at lung cancer multi-disciplinary team meetings (MDTs) reflect the actual treatment given in practice? Lung Cancer (Amsterdam, Netherlands). 2013;79:S36.","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"5","key":"1565_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1565_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/bjc.2012.350","volume":"107","author":"JR Lieffers","year":"2012","unstructured":"Lieffers JR et al. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107(6):931\u20136.","journal-title":"Br J Cancer"},{"issue":"7","key":"1565_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1477-2574.2011.00301.x","volume":"13","author":"PD Peng","year":"2011","unstructured":"Peng PD et al. Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford). 2011;13(7):439\u201346.","journal-title":"HPB (Oxford)"},{"issue":"4","key":"1565_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/bjs.7823","volume":"99","author":"MG Vledder van","year":"2012","unstructured":"van Vledder MG et al. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99(4):550\u20137.","journal-title":"Br J Surg"},{"issue":"7","key":"1565_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1565_CR27","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920\u20136.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1565_CR28","doi-asserted-by":"publisher","first-page":"e37563","DOI":"10.1371\/journal.pone.0037563","volume":"7","author":"O Mir","year":"2012","unstructured":"Mir O et al. Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One. 2012;7(5):e37563.","journal-title":"PLoS One"},{"issue":"5","key":"1565_CR29","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/bjc.2013.58","volume":"108","author":"O Huillard","year":"2013","unstructured":"Huillard O et al. Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer. 2013;108(5):1034\u201341.","journal-title":"Br J Cancer"},{"issue":"10","key":"1565_CR30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","volume":"61","author":"BH Goodpaster","year":"2006","unstructured":"Goodpaster BH et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059\u201364.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"1565_CR31","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","volume":"50","author":"I Janssen","year":"2002","unstructured":"Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889\u201396.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"1565_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","volume":"147","author":"RN Baumgartner","year":"1998","unstructured":"Baumgartner RN et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755\u201363.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"1565_CR33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"issue":"5","key":"1565_CR34","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/JTO.0b013e31819e77e8","volume":"4","author":"G Kasymjanova","year":"2009","unstructured":"Kasymjanova G et al. Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol. 2009;4(5):602\u20137.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1565_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/COC.0b013e3182019f03","volume":"35","author":"G Sonpavde","year":"2012","unstructured":"Sonpavde G et al. Objective measures of physical functional capacity warrant exploration to complement or replace the subjective physician estimated performance status. Am J Clin Oncol. 2012;35(2):163\u20136.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"1565_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.lungcan.2006.10.006","volume":"55","author":"LW Jones","year":"2007","unstructured":"Jones LW et al. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer. 2007;55(2):225\u201332.","journal-title":"Lung Cancer"},{"key":"1565_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2407-13-135","volume":"13","author":"CL Granger","year":"2013","unstructured":"Granger CL et al. Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties. BMC Cancer. 2013;13:135.","journal-title":"BMC Cancer"},{"issue":"12","key":"1565_CR38","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0003-9993(96)90187-2","volume":"77","author":"ME Cress","year":"1996","unstructured":"Cress ME et al. Continuous-scale physical functional performance in healthy older adults: a validation study. Arch Phys Med Rehabil. 1996;77(12):1243\u201350.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"1565_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jamda.2012.10.009","volume":"14","author":"DM Mijnarends","year":"2013","unstructured":"Mijnarends DM et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc. 2013;14(3):170\u20138.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"1565_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/ageing\/afs099","volume":"41","author":"E Freiberger","year":"2012","unstructured":"Freiberger E et al. Performance-based physical function in older community-dwelling persons: a systematic review of instruments. Age Ageing. 2012;41(6):712\u201321.","journal-title":"Age Ageing"},{"issue":"10","key":"1565_CR41","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.biocel.2013.06.016","volume":"45","author":"V Baracos","year":"2013","unstructured":"Baracos V, Kazemi-Bajestani SM. Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses. Int J Biochem Cell Biol. 2013;45(10):2302\u20138.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"1565_CR42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajcn\/46.4.537","volume":"46","author":"HC Lukaski","year":"1987","unstructured":"Lukaski HC. Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr. 1987;46(4):537\u201356.","journal-title":"Am J Clin Nutr"},{"issue":"21","key":"1565_CR43","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","volume":"24","author":"KC Fearon","year":"2006","unstructured":"Fearon KC et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006;24(21):3401\u20137.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1565_CR44","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ajcn\/80.6.1634","volume":"80","author":"D Gupta","year":"2004","unstructured":"Gupta D et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr. 2004;80(6):1634\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"1565_CR45","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00520-003-0486-0","volume":"11","author":"N Sarhill","year":"2003","unstructured":"Sarhill N et al. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer. 2003;11(10):652\u20139.","journal-title":"Support Care Cancer"},{"issue":"968","key":"1565_CR46","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/pgmj.2005.041699","volume":"82","author":"AB Rajasekaran","year":"2006","unstructured":"Rajasekaran AB et al. Effect of a multidisciplinary lung investigation day on a rapid access lung cancer service. Postgrad Med J. 2006;82(968):414\u20136.","journal-title":"Postgrad Med J"},{"issue":"9","key":"1565_CR47","first-page":"265","volume":"104","author":"E Dunican","year":"2011","unstructured":"Dunican E et al. Outcomes of patients presenting to a dedicated rapid access lung cancer clinic. Ir Med J. 2011;104(9):265\u20138.","journal-title":"Ir Med J"},{"issue":"6","key":"1565_CR48","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.bone.2005.11.007","volume":"38","author":"GM Blake","year":"2006","unstructured":"Blake GM, Naeem M, Boutros M. Comparison of effective dose to children and adults from dual X-ray absorptiometry examinations. Bone. 2006;38(6):935\u201342.","journal-title":"Bone"},{"issue":"2","key":"1565_CR49","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85\u201394.","journal-title":"J Gerontol"},{"key":"1565_CR50","unstructured":"Cancer Research UK. Performance status. [cited 2014 09\/01\/2014]; Available from: http:\/\/www.cancerresearchuk.org\/cancer-help\/about-cancer\/cancer-questions\/performance-status ."},{"issue":"5","key":"1565_CR51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1079\/BJN20041258","volume":"92","author":"RJ Stratton","year":"2004","unstructured":"Stratton RJ et al. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the \u2018malnutrition universal screening tool\u2019 (\u2018MUST\u2019) for adults. Br J Nutr. 2004;92(5):799\u2013808.","journal-title":"Br J Nutr"},{"issue":"2","key":"1565_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1017\/S000711451100571X","volume":"108","author":"C Boleo-Tome","year":"2012","unstructured":"Boleo-Tome C et al. Validation of the Malnutrition Universal Screening Tool (MUST) in cancer. Br J Nutr. 2012;108(2):343\u20138.","journal-title":"Br J Nutr"},{"key":"1565_CR53","first-page":"73","volume-title":"Cancer of the Lung., in SEER Survival Monograph: Cancer survival among adults: US SEER Program, 1998\u20132001","author":"LA Gloeckler","year":"2007","unstructured":"Gloeckler LA, Eisner MP. Cancer of the Lung., in SEER Survival Monograph: Cancer survival among adults: US SEER Program, 1998\u20132001. Bethesda, MD: National Cancer Institute; 2007. p. 73\u201380."},{"key":"1565_CR54","unstructured":"National Institute for Health and Clinical Excellence, Lung Cancer: The diagnosis and treatment of lung cancer. NICE clinical guideline 121. 2011, NICE."},{"issue":"16","key":"1565_CR55","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1200\/JCO.2005.02.148","volume":"23","author":"R Knols","year":"2005","unstructured":"Knols R et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol. 2005;23(16):3830\u201342.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1565_CR56","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1158\/1055-9965.EPI-04-0703","volume":"14","author":"KH Schmitz","year":"2005","unstructured":"Schmitz KH et al. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1588\u201395.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"1565_CR57","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ejon.2012.09.003","volume":"17","author":"C Andersen","year":"2013","unstructured":"Andersen C et al. The effects of a six-week supervised multimodal exercise intervention during chemotherapy on cancer-related fatigue. Eur J Oncol Nurs. 2013;17(3):331\u20139.","journal-title":"Eur J Oncol Nurs"},{"issue":"2","key":"1565_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.lungcan.2011.07.006","volume":"75","author":"M Quist","year":"2012","unstructured":"Quist M et al. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer. 2012;75(2):203\u20138.","journal-title":"Lung Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1565-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1565-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1565-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1565-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T13:05:52Z","timestamp":1566997552000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1565-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1565"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1565-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]},"article-number":"544"}}